## GE: GE Aerospace - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.0% below STRENGTH zone (3.0-6.0%); PEG 5.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($295.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. 7 Newly Overvalued Stocks this Week**
- Source: Morningstar | 20251230T020940 | Somewhat-Bearish | Relevance: 93%
- Seven US-listed stocks have recently been deemed overvalued by Morningstar, with their ratings shifting to 1 or 2 stars based on their price relative to fair value estimates and uncertainty ratings. Notable companies among these include GE Aerospace, Wells Fargo, Novartis, Capital One Financial, and EchoStar, all moving to a 2-star rating, while Take-Two Interactive Software is now a 1-star stock. This comes as the overall US stock market is considered slightly overvalued, trading at a 2% premium to its fair value estimate.

**2. Q3 Earnings Outperformers: Illinois Tool Works (NYSE:ITW) And The Rest Of The General Industrial Machinery Stocks**
- Source: FinancialContent | 20251229T030828 | Bullish | Relevance: 75%
- The general industrial machinery sector had a strong Q3, with revenues beating estimates by 1.6%. Illinois Tool Works (ITW) reported mixed results, with an EPS beat but a slight revenue miss, while Hillenbrand (HI) outperformed expectations significantly. Albany (AIN) had the weakest performance, missing analyst estimates, and Kadant (KAI) showed strong results but weak full-year guidance. GE Aerospace (GE) delivered exceptional performance, beating analyst estimates by a significant margin.

**3. NextNRG signs MOU with A123 for US-made battery storage systems**
- Source: Investing.com Australia | 20251230T110915 | Somewhat-Bullish | Relevance: 73%
- NextNRG, Inc. announced a Memorandum of Understanding with A123 Systems to deploy US-manufactured battery energy storage systems, aiming to avoid import tariffs and mitigate trade risks. This collaboration will focus on integrating A123's systems into NextNRG's U.S. energy projects and may include evaluating a U.S.-based manufacturing facility. The move aligns with NextNRG's significant revenue growth and strategic initiatives in the burgeoning U.S. battery storage market.

**4. Pacer Advisors Inc. Has $5.24 Million Stake in GE HealthCare Technologies Inc. $GEHC**
- Source: MarketBeat | 20251230T111205 | Somewhat-Bearish | Relevance: 72%
- Pacer Advisors Inc. reduced its stake in GE HealthCare Technologies by 16.8% to 69,744 shares, now valued at approximately $5.24 million, although institutional investors overall own 82.06% of the stock. Despite a split among analysts, the consensus is a "Moderate Buy" with an average price target of $87.09, reflecting recent target increases by several firms. GE HealthCare exceeded Q3 earnings estimates with EPS of $1.07 and revenue of $5.14 billion, and has provided FY25 guidance of $4.51â€“$4.63 EPS.

**5. Honeywell stock edges down after $58.8 million Army contract update as Fed minutes loom**
- Source: ts2.tech | 20251230T043551 | Somewhat-Bearish | Relevance: 64%
- Honeywell International Inc. shares dipped 0.14% after a U.S. Army contract notice showed a $58.79 million modification related to the AGT 1500 engine platform. This minor market movement occurred in thin year-end trading as investors await Federal Reserve minutes, which could influence interest rate expectations. Despite the small contract update, the stock's modest decline was in line with a broader market dip and mirrored movements in other industrial and aerospace-linked companies.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Citigroup | $386 | $0 | 0% |
| 2025-12-04 | Susquehanna | $350 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Citigroup | init | Buy |
| 2025-12-04 | Susquehanna | init | Positive |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($10.00M) |
| Sells | 2 ($2.77M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.7% (+0.1%)
- Blackrock Inc.: 8.3% (+5.3%)
- FMR, LLC: 5.2% (-9.1%)
- TCI Fund Management : 4.5% (0.0%)
- Capital Internationa: 4.2% (-5.8%)

### Key Risks

1. Valuation stretched: PEG 5.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.75 signals overvaluation risk, limited margin of safety. Forward P/E 42.7x stretched relative to 16% growth. Quality metrics strong (ROE 42%, margin 18%). Balance sheet: $2.2B free cash flow. Insider buying signal ($10.0M), management confidence. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $326.6B |
| Beta | 1.41 |
| 52W Range | $159.36 - $318.06 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.75 |
| Forward P/E | 42.7 |
| Current P/E | 49.4 |
| YoY Growth | 15.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 2.8% to 0.0% (-2.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.45), confirming momentum. RSI neutral at 55. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.03% (CS: 61) | Neutral |
| RSI_14 | 55.3 | Neutral |
| MACD Histogram | 1.45 | Bullish |
| vs SMA20 | 1.026x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 1.175x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $308.04
- **Stop Loss:** $295.04 (4.2% risk)
- **Target:** $321.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 92
- **Position Value:** $28,339.68
- **Portfolio %:** 28.34%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with mixed signals requiring caution. VIX at 14.95 suggests calm markets, but record repo borrowing and narrowing breadth (51.4%) indicate stress beneath the surface. Positive yield curve (+62bps) and stable economic data support risk assets, but year-end dynamics mask true liquidity conditions.*

### Earnings

**Next:** 2026-01-22 (Est: $1.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.47 | $1.66 | +13.0% |
| 2025Q2 | $1.43 | $1.66 | +16.0% |
| 2025Q1 | $1.27 | $1.49 | +17.5% |
| 2024Q4 | $1.04 | $1.32 | +26.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*